FDA Health Claims Guidance Chilling For Consumers’ Options – AAHF
This article was originally published in The Tan Sheet
A group promoting greater access to alternative medicines says FDA's proposed evidence-based review system for industry to evaluate health claims poses "grave consequences" for consumers seeking options to medication for their health care
You may also be interested in...
FDA's apparent contention that results from randomized controlled trials invalidate conflicting information from observational studies on the effects of nutrients reflects "an intrinsic bias" within the agency or "a lack of fundamental understanding of research methods," according to the Council for Responsible Nutrition
"Scientific conclusions from observational studies cannot be drawn about a relationship between a food component and a disease," FDA concludes in draft guidance for health claim petitioners
More FDA enforcement action is focusing on regulatory compliance by nutritional supplement firms in part because there is "plenty of room for shenanigans" in marketing the products, according to John Avellanet, a compliance consultant